Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

AZN

Astrazeneca (AZN)

Astrazeneca Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:AZN
DateTimeSourceHeadlineSymbolCompany
21/05/202421:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202421:18Alliance NewsAlliance NewsEXTRA: AstraZeneca pins hopes on pipeline as plans new era of growthLSE:AZNAstrazeneca Plc
21/05/202417:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202417:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aimLSE:AZNAstrazeneca Plc
21/05/202416:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to deliver $80bn revenue by 2030LSE:AZNAstrazeneca Plc
20/05/202417:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202417:24Alliance NewsAlliance NewsTOP NEWS: AstraZeneca plans to build manufacturing plant in SingaporeLSE:AZNAstrazeneca Plc
20/05/202416:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca to manufacture ADCs in SingaporeLSE:AZNAstrazeneca Plc
16/05/202419:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202419:27Alliance NewsAlliance NewsAstraZeneca trials yield positive results for immunocompromised patientsLSE:AZNAstrazeneca Plc
16/05/202416:00RNS Regulatory NewsAstraZeneca PLC SUPERNOVA Trial Met COVID-19 prevention endpointLSE:AZNAstrazeneca Plc
16/05/202400:00RNS Regulatory NewsAstraZeneca PLC Director/PDMR ShareholdingLSE:AZNAstrazeneca Plc
08/05/202418:44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
08/05/202418:44Alliance NewsAlliance NewsAstraZeneca says withdraws Covid vaccine "for commercial reasons"LSE:AZNAstrazeneca Plc
07/05/202416:00RNS Regulatory NewsAstraZeneca PLC AstraZeneca completes Cellectis equity investmentLSE:AZNAstrazeneca Plc
06/05/202416:46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
06/05/202416:46Alliance NewsAlliance NewsAstraZeneca completes collaboration and investment deal with CellectisLSE:AZNAstrazeneca Plc
02/05/202419:04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202419:04Alliance NewsAlliance NewsAstraZeneca notes positive trial results for Calquence treatmentLSE:AZNAstrazeneca Plc
02/05/202416:00RNS Regulatory NewsAstraZeneca PLC Calquence combination improved PFS in 1L MCLLSE:AZNAstrazeneca Plc
02/05/202400:00RNS Regulatory NewsAstraZeneca PLC Total Voting RightsLSE:AZNAstrazeneca Plc
29/04/202418:13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202418:13Alliance NewsAlliance NewsAstraZeneca makes progress with Truqap and Enhertu cancer treatmentsLSE:AZNAstrazeneca Plc
29/04/202416:05RNS Regulatory NewsAstraZeneca PLC Truqap recommended for EU breast cancer approvalLSE:AZNAstrazeneca Plc
29/04/202416:00RNS Regulatory NewsAstraZeneca PLC Enhertu improved PFS in HER2-low and ultralowLSE:AZNAstrazeneca Plc
25/04/202422:00PR Newswire (US)AbelZeta Announces Abstract for C-CAR031 Accepted for Presentation at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLSE:AZNAstrazeneca Plc
25/04/202418:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202418:18Alliance NewsAlliance NewsTOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growthLSE:AZNAstrazeneca Plc
25/04/202416:00RNS Regulatory NewsAstraZeneca PLC 1st Quarter ResultsLSE:AZNAstrazeneca Plc
24/04/202419:32Alliance NewsAlliance NewsAngle shares jump on supplier agreement with with AstraZenecaLSE:AZNAstrazeneca Plc
 Showing the most relevant articles for your search:LSE:AZN